title: Safe prescribing practices in pregnancy and lactation.
abstract: Midwives and other health care providers face a dilemma when a pregnant woman develops a condition that usually is treated with a pharmacologic agent. Understanding of basic teratology associated with drugs as well as the FDA categorization of agents can assist professionals in recognizing which pharmaceuticals should be used or avoided. In addition to reviewing teratology, this article addresses the use of common drugs for the treatment of upper respiratory conditions, minor pain, gastrointestinal problems, psychiatric illnesses, and neurologic disorders. In each category, current evidence is presented pertaining to which agents should be recommended for pregnant women.
authors.affiliation: University of Iowa Hospitals and Clinics, USA.
authors.forename: Wendy F
authors.initials: WF
authors.lastname: Hansen
authors.forename: Anne E
authors.initials: AE
authors.lastname: Peacock
authors.forename: Jerome
authors.initials: J
authors.lastname: Yankowitz
mesh_terms: D000014:Abnormalities, Drug-Induced / Q000517:prevention & control*; D005314:Embryonic and Fetal Development / Q000187:drug effects*; D005260:Female; D006801:Humans; D007774:Lactation / Q000187:drug effects*; D008880:Midwifery / Q000379:methods; D011247:Pregnancy; D011248:Pregnancy Complications / Q000628:therapy*; D013723:Teratogens / Q000145:classification
chemical_list: D013723:Teratogens